Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Operations BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount Aditxt Inc ADTX Q3 2025 Earnings Heavy PerShare Loss and Sharp Stock Decline Amid Ongoing PreRevenue Phase DSGN Q1 2026 Earnings Narrowerthanexpected loss drives positive sentiment